Acumen Research & Consulting estimates that global Haemodialysis Catheters market is expected to reach the market value of around US$ 1.8 Bn by 2028 and is anticipated to grow at a CAGR of around 4.2% in terms of revenue during the forecast period 2021 - 2028.
Haemodialysis is a procedure that is used after the kidney dies and no longer allows blood to be washed and extra fluid to be drained from the body. Catheters are used for blood exchange to and from the haemodialysis machine and the patient. Vascular access allows life-saving hemodialysis treatments. The access is generated by a vein that permits blood flow during hemodialysis. Weeks or months before the first treatment for hemodialysis, a vascular access should be in place. For hemodialysis, a tunnel catheter is used when placed under the skin. The most common method for chronic insufficiency treatment is haemodialysis. This therapy helps a human to live normal lives following a kidney failure. People traveling regularly and being diagnosed with haemodialysis will have access to dialysis. The catheter of hemodialysis is opted quickly if renal disease is progressed. For those unable to do peritoneal dialysis themselves, haemodialysis is prescribed. Central veins are usually placed in the neck , chest or groin in the vein. This catheter type is not used for permanent access since it may become obstructed or infected. The catheter line PICC is an in-arm catheter inserted in the vein. The tunnel catheter is inserted into the neck or chest underneath the skin.
The report provides analysis of global Haemodialysis Catheters market for the period 2017-2028, where in 2021 to 2028 is the forecast period and 2020 is considered as the base year.
Rising CKD prevalence and associated risk factors such as cardiovascular disorders, diabetes and hypertension are primary drivers for global target market. According to figures from the American Kidney Fund–2015, more than 31 Mn individuals in the US are affected by a chronic kidney condition, nearly 10 percent of the country's adult population. Opportunities to have CKD grow with age. The group has reported that 44% and 28.4% of the new cases of kidney disease are responsible for diabetes and hypertension. Increased hemodialysis demand among CKD patients around the world also increases the lack of available kidney donors for transplantation. In turn, this drives the market for catheters for hemodialysis.
The global awareness of blood infections (BSIs) is a key driver on the hemodialysis catheters market. Intravascular devices are primarily caused by the insertion of health-associated blood stream infections, especially catheters. This promotes the market for catheters for hemodialysis. Blood infections and thrombosis are a major restraint for the hemodialysis catheter market. The primary motive of mortality in ESRD patients is infection, while vascular systems are inevitably used in hemodialysis as the main risk factor for infection. There has been a trend to use carbothane or polyurethane-based catheters that have better strength and softness compared with silicone in order to overcome catheter-based thrombosis. Furthermore, catheter surfaces are protected against infection and thrombosis by antimicrobials and anti-thrombogenic.
The business was dominated by North America in 2020 and retained a 39 percent share that year due to leading to a rise in health diseases like kidney disease, diabetes, high blood pressure, etc. Due to better health infrastructure and the presence of leading market players, the United States has led the hemodialysis market. According to the Center for the Control and Prevention of Diseases, the number of chronic kidney disease in US adults or 37 Mn persons, or between 65 and 38% of those aged between 45-64 years and 18-44 year-olds, is estimated to be between 15 and 37 Mn.
The Population Reference Bureau estimates that the number of Americans 65 and over will almost double from 52 Mn in 2018 to 95 Mn by 2060. Ageing and increasing the risk of chronic kidney disease were projected to increase regional growth considerably.
Key Players & Strategies
Participants include major global Nikkiso Co. Ltd, Fresenius Medical Care AG & Co. KGaA, B. Braun Melsungen AG, Outset Medical, Inc, Baxter International Inc., Toray Medical Co., Ltd., Asahi Kasei Medical Co., Ltd., Nipro Medical Corporation, and Others.
The major players in Haemodialysis Catheter's market follow a range of development initiatives, such as product releases, acquisitions, sales, alliances and collaborations.
Following approval by US anti-trust authorities, Fresenius Medical Care was acquired in February 2020 as the world's largest provider of dialysis products and services.
Haemodialysis Catheters Market By Product
Haemodialysis Catheters Market By Configuration
Haemodialysis Catheters Market By Material
Haemodialysis Catheters Market by End Use
Haemodialysis Catheters Market By Region
• Rest of Europe
• South Korea
• Rest of Asia-Pacific
• Rest of Latin America
Middle East & Africa
• South Africa
• Rest of Middle East & Africa
The Haemodialysis Catheters market value is anticipated to be worth around US$ 1.8 Bn in 2028.
The Haemodialysis Catheters market is anticipated to grow around 4.2% CAGR amid the forecast period 2021-2028.
North America held highest market share in 2019.
Asia Pacific is projected to be the fastest growing region in the global market.
Growing incidence of kidney disease.
Side effects of same is the main challenge in the global market.
Nikkiso Co. Ltd, Fresenius Medical Care AG & Co. KGaA, B. Braun Melsungen AG, Outset Medical, Inc, Baxter International Inc., Toray Medical Co., Ltd., Asahi Kasei Medical Co., Ltd., Nipro Medical Corporation, and Others are the prominent players in the Haemodialysis Catheters market.